Last update 28 Nov 2024
RD13-02
Last update 28 Nov 2024
Overview
Basic Info
Drug Type Universal CAR-T |
Synonyms RD13 02 |
Target |
Mechanism CD7 modulators(T-cell antigen CD7 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with RD13-02A Clinical Study of Safety, Efficacy, and Pharmacokinetics of Universal CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
Clinical Study on Efficacy, Safety and Cytopharmacokinetics of RD13-02 Cell Injection in the Treatment of Patients With Recurrent or Refractory CD7-positive Hematologic Malignancies
Efficacy, Safety and Cytopharmacokinetics of RD13-02 Cell Injection in the Treatment of Patients With Recurrent or Refractory CD7-positive Hematologic Malignancies
100 Clinical Results associated with RD13-02
Login to view more data
100 Translational Medicine associated with RD13-02
Login to view more data
100 Patents (Medical) associated with RD13-02
Login to view more data
100 Deals associated with RD13-02
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia, Aplastic | Phase 1 | CN | 07 Oct 2024 | |
| CD7 positive Hematologic Neoplasms | Phase 1 | CN | 30 Apr 2023 | |
| Adult Lymphoblastic Lymphoma | Phase 1 | CN | 09 Feb 2023 | |
| Solid tumor | Phase 1 | CN | 09 Feb 2023 | |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | CN | 07 Feb 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT05716113 (EHA2024) Manual  | Phase 1 | 12 | vszqsuhvna(qihzbydisg) = None dmimiwmwpy (hkjrlxroic ) View more | Positive | 14 May 2024 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free